Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
Diabetes, Obesity & Metabolism
|
March 4, 2015
Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial
D D Kim, J Krishnarajah, S Lillioja, et al.
Diabetes, Obesity & Metabolism
|
April 7, 2005
Effect of orlistat on cardiovascular disease risk in obese adults
B A Swinburn, D Carey, A P Hills, et al.
Obesity (Silver Spring, Md.)
|
March 21, 2013
Fat mass is a predictor of incident foot pain
P A Butterworth, D M Urquhart, F M Cicuttini, et al.
International Journal of Obesity (2005)
|
March 10, 2010
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study
J Proietto, A Rissanen, J B Harp, et al.
Journal of Molecular Endocrinology
|
December 11, 2003
Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy
S J Kaczmarczyk, S Andrikopoulos, J Favaloro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2000
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
M E Jones, A W Thorburn, K L Britt, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 19, 2002
Aromatase-deficient (ArKO) mice accumulate excess adipose tissue
M E Jones, A W Thorburn, K L Britt, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
Diabetes, Obesity & Metabolism
|
March 4, 2015
Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial
D D Kim, J Krishnarajah, S Lillioja, et al.
Diabetes, Obesity & Metabolism
|
April 7, 2005
Effect of orlistat on cardiovascular disease risk in obese adults
B A Swinburn, D Carey, A P Hills, et al.
Obesity (Silver Spring, Md.)
|
March 21, 2013
Fat mass is a predictor of incident foot pain
P A Butterworth, D M Urquhart, F M Cicuttini, et al.
International Journal of Obesity (2005)
|
March 10, 2010
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study
J Proietto, A Rissanen, J B Harp, et al.
Journal of Molecular Endocrinology
|
December 11, 2003
Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy
S J Kaczmarczyk, S Andrikopoulos, J Favaloro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 9, 2000
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
M E Jones, A W Thorburn, K L Britt, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 19, 2002
Aromatase-deficient (ArKO) mice accumulate excess adipose tissue
M E Jones, A W Thorburn, K L Britt, et al.
Page
of 11